To validate the role of SLC6A8 in mediating VTN‐induced oncogenic effects and M2 polarization, we initially conducted knockdown experiments targeting SLC6A8 expression in CRC cells (Figure S8A, Supporting Information). The gene discussed is VTN; the disease is colorectal carcinoma.